Design, synthesis, and characterization of heparin-binding peptoids

Biochemistry

Volumn 52, Issue 21, 2013, Pages 3773-3780

  Ford, Bruce Kevin ^a   Hamza, Mark ^a   Rabenstein, Dallas L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT ACTIVITIES; HELICAL STRUCTURES; HEPARIN AFFINITY CHROMATOGRAPHY; HIGH AFFINITY BINDING; ISOTHERMAL TITRATION CALORIMETRY; NEGATIVELY CHARGED; SECONDARY STRUCTURES; SOLID PHASE SYNTHESIS;

AMINO ACIDS; BINDING ENERGY; DESIGN; OLIGOMERS; SUBSTITUTION REACTIONS; SYNTHESIS (CHEMICAL);

POLYSACCHARIDES;

AMMONIA; BLOOD CLOTTING FACTOR 10A; GLYCINE; GUANIDINE; HEPARIN; HEPARIN BINDING PEPTOID; HEPARIN BINDING PROTEIN; MONOMER; PEPTOID; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; AMINO TERMINAL SEQUENCE; ANTICOAGULATION; ARTICLE; BINDING AFFINITY; CHIRALITY; CIRCULAR DICHROISM; DRUG ANTAGONISM; DRUG DESIGN; DRUG PROTEIN BINDING; DRUG SCREENING; DRUG SYNTHESIS; ELECTRICITY; ISOTHERMAL TITRATION CALORIMETRY; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; SOLID PHASE SYNTHESIS; STATIC ELECTRICITY;

AMINO ACID SEQUENCE; CALORIMETRY; CHROMATOGRAPHY, AFFINITY; CIRCULAR DICHROISM; HEPARIN; MOLECULAR SEQUENCE DATA; PEPTOIDS; THERMODYNAMICS;

EID: 84878325210     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi4001722     Document Type: Article

References (36)

1. Rabenstein, D. L. (2002) Heparin and heparan sulfate: structure and function Nat. Prod. Rep. 19, 312-331
2. Capila, I. and Linhardt, R. J. (2002) Heparin-protein interactions Angew. Chem., Int. Ed. 41, 390-412
3. Coombe, D. R. and Kett, W. C. (2005) Heparan sulfate-protein interactions: therapeutic potential through structure-function insights Cell. Mol. Life Sci. 62, 410-424
4. Cox, M. and Nelson, D. (2000) Lehninger Principles of Biochemistry, 3 rd ed., p 310, W. H. Freeman, New York.
5. Folkman, J., Langer, R., Linhardt, R. J., Haudenschild, C., and Taylor, S. (1983) Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone Science 221, 719-725
6. Lyon, M., Rushton, G., Askari, I. A., Humphries, M. J., and Gallagher, J. T. (2000) Elucidation of the structural features of heparan sulfate important for interaction with the Hep-2 domain of fibronectin J. Biol. Chem. 275, 4599-4606
7. Conrad, H. E. (1998) Heparin-Binding Proteins, Academic Press, New York.
8. Guyton, A. C. and Hall, J. E. (2006) Textbook of Medical Physiology, p 464, Elsevier Saunders, Philadelpha.
9. Carr, J. A. and Silverman, N. (1999) The heparin-protamine interaction. A review J. Cardiovasc. Surg. (Torino) 40, 659-666
10. Liu, S., Zhou, F., Hook, M., and Carson, D. D. (1997) A heparin-binding synthetic peptide of heparin/heparan sulfate-interacting protein modulates blood coagulation activities Proc. Natl. Acad. Sci. U. S. A. 94, 1739-1744
11. Schick, B. P., Gradowski, J. F., San Antonio, J. D., and Martinez, J. (2001) Novel design of peptides to reverse the anticoagulant activities of heparin and other glycosaminoglycans Thromb. Haemost. 85, 482-487
12. Schick, B. P., Maslow, D., Moshinski, A., and San Antonio, J. D. (2004) Novel concatameric heparin-binding peptides reverse heparin anticoagulant activities in patient plasma in vitro and in rats in vivo Blood 103, 1356-1363
13. Wang, J. and Rabenstein, D. L. (2006) Interaction of heparin with two synthetic peptides that neutralize the anticoagulant activity of heparin Biochemistry 45, 15740-15747
14. Rohde, L. H., Julian, J., Babaknia, A., and Carson, D. D. (1996) Cell surface expression of HIP, a novel heparin/heparan sulfate binding protein, of human uterine epithelial cells and cell lines J. Biol. Chem. 271, 11824-11830
15. Simon, R. J., Kania, R. S., Zuckermann, R. N., Huebner, V. D., Jewell, D. A., Banville, S., Ng, S., Wang, L., Rosenberg, S., Marlowe, C. K., Spellmeyer, D. C., Tan, R. Y., Frankel, A. D., Santi, D. V., Cohen, F. E., and Bartlett, P. A. (1992) Peptoids: a modular approach to drug discovery Proc. Natl. Acad. Sci. U. S. A. 89, 9367-9371
16. Miller, S. M., Simon, R. J., Ng, S., Zuckcrmann, R. N., Kerr, J. M., and Moos, W. H. (1994) Proteolytic studies of homolologous peptide and N-substituted glycine peptoid oligomers Bioorg. Med. Chem. Lett. 4, 2657-2662
17. Miller, S. M., Simon, R. J., Ng, S., Zuckermann, R. N., Kerr, J. M., and Moos, W. H. (1995) Comparison of the proteolytic susceptibilities of homologous L-amino acid, D-amino acid, and N-substituted glycine peptide and peptoid oligomers Drug Dev. Res. 35, 20-32
18. Kwon, Y. U. and Kodadek, T. (2007) Quantitative evaluation of the relative cell permeability of peptoids and peptides J. Am. Chem. Soc. 129, 1508-1509
19. Schröder, T., Niemeier, N., Afonin, S., Ulrich, A. S., Krug, H. F., and Bräse, S. (2008) Peptoidic amino- and guanidinium-carrier systems: Targeted drug delivery into the cell cytosol or the nucleus J. Med. Chem. 51, 376-379
20. Gibbons, J. A., Hancock, A. A., Vitt, C. R., Knepper, S., Buckner, S. A., Brune, M. E., Milicic, I., Kerwin, J. F., Richter, L. S., Taylor, E. W., Spear, K. L., Zuckerman, R. N., Spelllmeyer, D. C., Braeckman, R. A., and Moos, W. H. (1996) Pharmacologic characterization of CHIR 279, an N-substituted glycine peptoid with high affinity for alpha 1-adrenoceptors Pharmacol. Exp. Ther. 277, 885-899
21. Astle, J. M., Udugamasooriya, D. G., Smallshaw, J. E., and Kodadek, T. (2008) A VEGFR2 antagonist and other peptoids evade immune recognition Int. J. Pept. Res. Ther. 14, 223-227
22. Zuckermann, R. N., Kerr, J. M., Kent, S. B., and Moos, W. H. (1992) Efficient method for the preparation of peptoids [oligo(N-substituted glycines)] by submonomer solid-phase synthesis J. Am. Chem. Soc. 114, 10646-10647
23. Sui, Q., Borchardt, D., and Rabenstein, D. L. (2007) Kinetics and equilibria of cis/trans isomerization of backbone amide bonds in peptoids J. Am. Chem. Soc. 127, 12042-12048
24. Wu, C. W., Sanborn, T. J., Huang, K., Zuckermann, R. N., and Barron, A. E. (2001) Peptoid oligomers with R-chiral, aromatic side chains: sequence requirements for the formation of stable peptoid helices J. Am. Chem. Soc. 123, 6778-6784
25. Armand, P., Kirshenbaum, K., Goldsmith, R. A., Farr-Jones, S., Barron, A. E., Truong, K. T. V., Dill, K. A., Mierke, D. F., Cohen, F. E., Zuckerman, R. N., and Bradley, E. K. (1998) NMR determination of the major solution conformation of a peptoid pentamer with chiral side chains Proc. Natl. Acad. Sci. U. S. A. 95, 4309-4314
26. Wu, C. W., Kirshenbaum, K., Sanborn, T. J., Patch, J. A., Huang, K., Dill, K. A., Zuckerman, R. N., and Barron, A. E. (2003) Structural and Spectroscopic Studies of Peptoid Oligomers with α-Chiral Aliphatic Side Chains J. Am. Chem. Soc. 125, 13525-13530
27. Bernatowicz, M., Wu, Y., and Matsueta, G. (1992) 1H-Pyrazole-1- carboxamidine hydrochloride an attractive reagent for guanylation of amines and its application to peptide synthesis J. Org. Chem. 57, 2497-2502
28. Sanborn, T. J., Wu, C. W., Zuckermann, R. N., and Barron, A. E. (2002) Extreme stability of helices formed by water-soluble poly-N-substituted glycines (polypeptoids) with α-chiral side chains Biopolymers 63, 12-20
29. Green, M. M., Peterson, N. C., Sato, T., Teramoto, A., Cook, R., and Lifson, S. (1995) A helical polymer with a cooperative response to chiral formation Science 268, 1860-1866
30. Kirshenbaum, K., Barron, A. E., Goldsmith, R. A., Armand, P., Bradley, E. K., Truong, K. T. V., Dill, K. A., Cohen, F. E., and Zuckermann, R. N. (1998) Sequence-specific polypeptoids: A diverse family of heteropolymers with stable secondary structure Proc. Natl. Acad. Sci. U. S. A. 95, 4303-4308
31. Yun, J. H., Meyerhoff, M. E., and Yang, V. C. (1995) Protamine-sensitive polymer membrane electrode: characterization and bioanalytical applications Analyt. Biochem. 224, 212-220
32. Ramamurthy, N., Baliga, N., Wakefield, T. W., Andrews, P. C., Yang, V. C., and Meyerhoff, M. E. (1999) Determination of low-molecular-weight heparins and their binding to protamine and a protamine analog using polyion-sensitive membrane electrodes Analyt. Biochem. 266, 116-124
33. Atkins, E. D. T. and Nieduszynski, I. A. (1975) Crystalline structure of heparin Adv. Exp. Med. Biol. 52, 19-37
34. Mulloy, B., Forster, M. J., Jones, C., and Davies, D. B. (1993) NMR and molecular modeling studies of the solution structure conformation of heparin Biochem. J. 293, 849-858
35. Fromm, J. R., Hileman, R. E., Caldwell, E. E. O., Weiler, J. M., and Linhardt, R. J. (1995) Differences in the interaction of heparin with arginine and lysine and the importance of these basic amino acids in the binding of heparin to acidic fibroblast growth factor Arch. Biochem. Biophys. 323, 279-287
36. Verrecchio, A., Germann, M. W., Schick, B. P., Kung, B., Twardowski, T., and San Antonio, J. D. (2000) Design of peptides with high affinities for heparin and endothelial cell proteoglycans J. Biol. Chem. 275, 7701-7707